Reflections
During the last 30 years, researchers from the Clinical Chemistry department of The University of Medicine and Pharmacy of Cluj Napoca were interested in elucidating the pathogenetic mechanisms responsable for thrombotic events in patients with atherosclerosis, and in implementing laboratory tests able to detect rare hemostasis abnormalities.
The researchers in Cluj brought arguments for the fact that abdominal obesity, (very susceptible to adrenergic stimulation) favors an accelerated lipolysis. This in its turn results in a massive secretion of free fatty acids which reach liver through the portal vein and stimulate the synthesis of VLDL incorporated triglycerides, as well as the production of hepatic proteins, such as fibrinolysis inhibitors (1). This mechanism also produces an increase of plasmatic level of coagulation FXIII, thus contributing to an increased resistance of the fibrin mesh to plasmin's proteolytic action (2) .
Inflammatory processes accompanying atherosclerosis perturbate the anticoagulant mechanisms (3), whereas the protein C system exerts not only anticoagulant effects but also diminishes inflammatory processes (4). According to clinical observation and laboratory data it was considered that the increase of plasmatic level of von Willebrand factor in patients with myocardial infarction is more likely a consequence of the reaction of endothelial cells to adrenergic and proinflammatory stimuli, rather than a simple leakage of vWF from injured endothelia (8) . This interpretation is accepted and cited by many authors such as Schorer et al (9), Pottinger et al (10) It is worth mentioning that some genetic hemostasis defects were detected by the research group in Cluj Napoca.
Several cases of von Willebrand disease (with impaired response to ristocetin) were described, as well as a case of Glanzmann's thrombasthenia, with severely impaired platelet aggregation when stimulated by various agonists, including ADP (11) .
A young man displaying a severe and prolongated bleeding after a dental extraction was investigated and diagnosed with an α2plasmin inhibitor deficiency (α2PI), this defect being associated with a quick clot lysis. The patient's father had the same deficiency, but being obese, and thus having an enhanced level of plasminogen activator inhibitor (PAI) did not display any bleeding disorders (12) .
Several cases of antithrombin genetic deficiency were also detected, including cases with heparin-binding site alteration (13) .
A heterozygous protein C deficiency was detected in a woman displaying a coumarin-induced skin necrosis (14) , this case being cited by Seyfarth HJ et al (15) . These cases were also included in the volume Hemostaza -Biochimie, fiziopatologie, clinică (16) .
